Myriad Genetics (NasdaqGS:MYGN) Q1 2026 Earnings call May 05, 2026 04:30 PM ET Company ParticipantsBen Wheeler - CFOBrian Donnelly - Chief Commercial OfficerKyle Boucher - VP of Healthcare Equity ResearchMatt Scalo - SVP of Investor RelationsPuneet Souda - Managing Director of Life Science Tools and DiagnosticsSam Raha - President and CEOSkye Mannino - Equity Research AssociateConference Call ParticipantsBrandon Couillard - Managing Director and Senior Equity Research AnalystMason Carrico - Managing Directo ...